Page last updated: 2024-11-06

4,6-diacetylresorcinol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4,6-Diacetylresorcinol is a diketone derivative of resorcinol. It is a white solid with a melting point of 148-149 °C. It is synthesized by the acetylation of resorcinol with acetic anhydride in the presence of a catalyst such as sulfuric acid. 4,6-Diacetylresorcinol has been studied for its potential applications in the synthesis of pharmaceuticals, dyes, and polymers. It has been shown to exhibit antimicrobial and antioxidant activity. Its importance lies in its versatility as a starting material for the synthesis of various other compounds. 4,6-Diacetylresorcinol has also been explored for its potential use in organic electronics.'

4,6-diacetylresorcinol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID75097
SCHEMBL ID1258995
MeSH IDM0518546

Synonyms (33)

Synonym
4,6-diacetylresorcinol
1,1'-(4,6-dihydroxybenzene-1,3-diyl)diethanone
STL356141
ethanone, 1,1'-(4,6-dihydroxy-1,3-phenylene)bis-
4,6-diacetyl-1,3-benzenediol
inchi=1/c10h10o4/c1-5(11)7-3-8(6(2)12)10(14)4-9(7)13/h3-4,13-14h,1-2h
1,1'-(4,6-dihydroxy-1,3-phenylene)bisethanone, 99%
AKOS000277669
1-(5-acetyl-2,4-dihydroxyphenyl)ethanone
2161-85-5
1,1'-(4,6-dihydroxy-1,3-phenylene)-bis-ethanone
1,1'-(4,6-dihydroxy-1,3-phenylene)diethanone
A815533
1,3-diacetyl-4,6-dihydroxybenzene
1,1'-(4,6-dihydroxy-1,3-phenylene)bisethanone
1,1'-(4,6-dihydroxy-1,3-phenylene)bisethan-1-one
einecs 218-482-8
ethanone,1,1'-(4,6-dihydroxy-1,3-phenylene)bis-
FT-0634081
4,6-diacetyl resorcinol
SCHEMBL1258995
resodiacetophenone
DTXSID50175994
mfcd00017655
J-014183
1-(5-acetyl-2,4-dihydroxyphenyl)ethan-1-one
4,6-diacetyl-1,3-dihydroxybenzene
D5102
FS-4391
2-([imino(phenyl)methyl]amino)aceticacid
D84225
SY063326
CS-0155117
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (38.46)29.6817
2010's8 (61.54)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.76 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.47 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]